Vitamin-D receptor genotype and renal disorder in Japanese patients with systemic lupus erythematosus

Nephron

Volumn 85, Issue 1, 2000, Pages 86-91

  Ozaki, Yoshio ^a   Nomura, Shosaku ^a   Nagahama, Minori ^a   Yoshimura, Chie ^a   Kagawa, Hideo ^a   Fukuhara, Shirou ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Japanese; Lupus nephritis; Systemic lupus erythematosus; Vitamin d receptor genotype

Indexed keywords

COLECALCIFEROL; VITAMIN D RECEPTOR;

ADULT; ANTIBODY TITER; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; JAPAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0034054443     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045635     Document Type: Article

References (31)

1. Voll RE, Roth EA, Girkontaite I, Fehr H, Herrmann M, Lorenz HM, Kalden JR: Histone-specitic Th0 and Th1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production. Arthritis Rheum 1997;40:2162-2171.
2. Horwitz DA, Gray JD, Behrendsen SC, Kubin M, Rengaraju M, Ohtsuka K, Trinchieri G: Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arthritis Rheum 1998;41:838-844.
3. Mosmann TR, Coffman RL: TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173.
4. Lemire JM, Archer DC, Beck L, Spiegelberg HL: Immunosuppressive actions of 1,25-dihydroxy vitamin D3: Preferential inhibition of Th1 functions. J Nutr 1995;125(suppl):1704-1708.
5. Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, Pike JW, Shine J, O'Malley BW: Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 1988;85: 3294-3298.
6. Cancela L, Nemere I, Normal AW: 1 Alpha,25(OH)2 vitamin D3: A steroid hormone capable of producing pleiotropic receptor-mediated biological responses by both genomic and nongenomic mechanisms. J Steroid Biochem 1988;30:33-39.
7. Beato M: Gene regulation by steroid hormones. Cell 1989;56:335-344.
8. Alroy I, Towers TL, Freedman LP: Transcriptional repression of the interleukin-2 gene by vitamin D3: Direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 1995;15:5789-5799.
9. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA: Prediction of bone density from vitamin D receptor alleles. Nature 1994;367:284-287.
10. Morrison NA, Yeoman R, Kelly PJ, Eisman JA: Contribution of trans-acting factor alleles to normal physiological variability: Vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci USA 1992;89: 6665-6669.
11. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schalter JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-1277.
12. Tokita A, Matsumoto H. Morrison NA, Tawa T, Miura Y, Fukamauchi K, Mitsuhashi N, Irimoto M, Yamamori S, Miura M, Watanabe T, Kuwabara Y, Yabuta K, Eisman JA: Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women. J Bone Miner Res 1996;11:1003-1009.
13. Gibofsky A, Winchester R, Hansen J, Patarroyo M, Dupont B, Paget S, Lahita R, Halper J, Fotino M, Yunis E, Kunkel HG: Contrasting patterns of newer histocompatibility determinants in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 1978;21(suppl):134-138.
14. Lu LY, Ding WZ, Fici D, Deulofeut R, Cheng HH, Cheu CC, Sung PK, Schur PH, Fraser PA: Molecular analysis of major histocompatibility complex allelic associations with systemic lupus erythematosus in Taiwan. Arthritis Rheum 1997;40:1138-1145.
15. Tarassi K, Carthy D, Papasteriades C, Boki K, Nikolopoulou N, Carcassi C, Ollier WE, Hajeer AH: HLA-TNF haplotype heterogeneity in Greek SLE patients. Clin Exp Rheumatol 1998;16:66-68.
16. Savi M, Ferraccioli GF, Neri TM, Zanelli P, Dall'Aglio PP, Tincani A, Balestrieri G, Carella G, Cattaneo R: HLA-DR antigens and anticardiolipin antibodies in northern Italian systemic lupus erythematosus patients. Arthritis Rheum 1988;31:1568-1570.
17. Horwitz DA, Jacob CO: The cytokine network in the pathogenesis of systemic lupus erythematosus and possible therapeutic implications. Springer Semin Immunopathol 1994;16:181-200.
18. D'Ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, Lang R, Sinigaglia F, Panina-Bordignon P: Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 1998;101:252-262.
19. Kliewer SA, Umesono K, Mangelsdorf DJ, Evans RM: Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 1992; 355:446-449.
20. Schrader M. Bendik I, Becker-Andre M, Carlberg C: Interaction between retinoic acid and vitamin D signaling pathways. J Biol Chem 1993;268:17830-17836.
21. Schrader M, Muller KM, Carlberg C: Specificity and flexibility of vitamin D signaling. Modulation of the activation of natural vitamin D response elements by thyroid hormone. J Biol Chem 1994;269:5501-5504.
22. Nishikawa J, Kitaura M, Matsumoto M, Imagawa M, Nishihara T: Difference and similarity of DNA sequence recognized by VDR homodimer and VDR/RXR heterodimer. Nucleic Acids Res 1994;22:2902-2907.
23. Ingles SA, Coetzee GA, Ross RK, Henderson BE, Kolonel LN, Crocitto L, Wang W, Haile RW: Association of prostate cancer with vitamin D receptor haplotypes in African-Americans. Cancer Res 1998;58:1620-1623.
24. Carting T, Rastad J, Akerstrom G, Westin G: Vitamin D receptor (VDR) and parathyroid hormone messenger ribonueleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors. J Clin Endocrinol Metab 1998;83:2255-2259.
25. Evans SR, Nolla J, Hanfelt J, Shabahang M, Nauta RJ, Shehepotin IB: Vitamin D receptor expression as a predictive marker of biological behavior in human colorectal cancer. Clin Cancer Res 1998;4:1591-1595.
26. Koffler D, Agnello V, Thoburn R, Kunkel HG: Systemic lupus erythematosus: Prototype of immune complex nephritis in man. J Exp Med 1971;134:169-179.
27. Swaak AJ, Aarden LA, Statius van Eps LW, Feltkamp TE: Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum 1979;22:226-235.
28. Swaak AJ, Groenwold J, Aarden LA, Statius van Eps LW, Feltkamp EW: Prognostic value of anti-dsDNA in SLE. Ann Rheum Dis 1982; 41:388-395.
29. ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CG: Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. Arthritis Rheum 1990;33:634-643.
30. Rissoan MC, Soumelis V, Kadowaki N, Grouard G, Briere F, de Waal Malefyt R, Liu YJ: Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999;283: 1183-1186.
31. Sainz J, Van Tornout JM, Loro ML, Sayre J, Roe TF, Gilsanz V: Vitmain D-receptor gene polymorphisms and bone density in prepubertal American girls of Mexican descent. N Engl J Med 1997;337:77-82.